Travere Therapeutics, Inc.
TVTX
$29.73
$1.485.24%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -8.26% | -1.80% | -26.94% | -34.60% | -56.28% |
| Total Receivables | 205.33% | 47.50% | 37.50% | 14.11% | 48.21% |
| Inventory | -12.71% | -31.56% | -13.24% | -34.11% | -69.40% |
| Prepaid Expenses | 99.98% | 52.06% | 28.40% | -29.52% | 9.31% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 14.28% | 2.87% | -22.22% | -32.44% | -52.68% |
|
|
|||||
| Total Current Assets | 14.28% | 2.87% | -22.22% | -32.44% | -52.68% |
| Net Property, Plant & Equipment | -27.68% | -26.68% | -25.46% | -23.14% | -18.57% |
| Long-term Investments | 0.80% | 0.00% | 0.00% | 0.00% | -0.80% |
| Goodwill | 0.80% | 0.00% | 0.00% | 0.00% | -0.80% |
| Total Other Intangibles | 5.05% | 0.41% | 2.62% | -0.45% | -2.54% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -21.23% | -1.27% | -7.55% | 27.67% | 315.34% |
| Total Assets | 6.77% | 0.76% | -17.29% | -24.69% | -39.44% |
|
|
|||||
| Total Accounts Payable | -21.43% | -25.96% | -8.08% | -43.53% | -6.23% |
| Total Accrued Expenses | 26.57% | 3.94% | -44.28% | -20.03% | -12.70% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -92.24% | 1,341.66% | 1,373.75% | 1,409.13% | 1,445.29% |
| Total Finance Division Other Current Liabilities | -42.99% | 22.41% | 20.36% | -27.99% | -33.89% |
| Total Other Current Liabilities | -42.99% | 22.41% | 20.36% | -27.99% | -33.89% |
| Total Current Liabilities | -28.92% | 56.30% | 5.33% | 12.84% | 36.29% |
|
|
|||||
| Total Current Liabilities | -28.92% | 56.30% | 5.33% | 12.84% | 36.29% |
| Long-Term Debt | 0.46% | -17.75% | -17.75% | -17.75% | -17.75% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -31.95% | -29.16% | -26.80% | -23.97% | -22.13% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -63.61% | -52.64% | -57.87% | -34.15% | 25.73% |
| Total Liabilities | -13.06% | -2.50% | -12.47% | -9.02% | -3.29% |
|
|
|||||
| Common Stock & APIC | 14.19% | 13.78% | 13.79% | 13.44% | 2.93% |
| Retained Earnings | -6.38% | -12.69% | -17.97% | -28.57% | -33.94% |
| Treasury Stock & Other | -3.74% | 50.31% | 55.44% | 94.51% | 72.19% |
| Total Common Equity | 341.56% | 116.19% | -55.69% | -70.58% | -110.89% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 341.56% | 116.19% | -55.69% | -70.58% | -110.89% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 341.56% | 116.19% | -55.69% | -70.58% | -110.89% |
|
|
|||||